_id
690f359bccc777a4e85d16f7
Ticker
BIVIW
Name
BioVie Inc. Warrant
Exchange
NASDAQ
Address
680 W. Nye Lane, Carson City, NV, United States, 89703
Country
USA
Sector
Industry
Currency
USD
Website
https://bioviepharma.com
Description
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Last Close
0.282
Volume
644
Current Price
0.291
Change
0.009
Last Updated
2026-01-19T10:43:44.276Z
Image
data:image/webp;base64,UklGRkgBAABXRUJQVlA4IDwBAAAQCACdASpAAEAAPrVOoEsnJCMhsBgIAOAWiWMA0Q2w8YFbGgZ91Dc73JKoJ8E7+u9BnVZOCwCT/3apV/DNOadBs+7ISV7cZswAAP7yIl/2p+9n4T9B6TiCjr54pJqkG0zxoTLSxxnUl5ch0Rh4KnVOvYmiCb+Mn9+5OQ3KImSdqO2ABkMRYwa7OKnlOXkH7MfYFvppg7/NRKuBKDde6Q33m59AHQ/UAcJlfeiZDbFVQapm1kABpcaja+07Rl58AdpTSuKlB17jKBdnjfFt7zDB3r1wHxugsXEFXKXHwf7tnmIdSPYP1H32EplafhPkinAScl7iS67XvLK4IVfNl+t7wYBJse96cXfDNzxApGaUVqJsPKHaQawwjfThFMvtUUsDdF6Uxt+fybO/vFulYOFszSls3gEoAfVMM3AA
Ipo Date
2025-08-08T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
5284595
Operating Income
-5284595
Interest Expense
1989
Pretax Income
-5087557
Net Income
-5087557
Eps
-0.6749679833270514
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
24978302
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
26031990
Property Plant Equipment
321400
Total Assets
26820098
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1899094
Equity
24921004
Bs_currency_symbol
USD
Depreciation
57344
Change In Working Capital
1449139
Cash From Operations
-3023874
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
10457629
Net Change In Cash
7433755
Cf_currency_symbol
USD
PE
-
PB
0.08801436687703271
ROE
-20.414735297181448
ROA
-18.969196160282486
FCF
-3023874
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
4.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
5284595
Quarters > 0 > income Statement > operating Income
-5284595
Quarters > 0 > income Statement > interest Expense
1989
Quarters > 0 > income Statement > pretax Income
-5087557
Quarters > 0 > income Statement > net Income
-5087557
Quarters > 0 > income Statement > eps
-0.6749679833270514
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7537479
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
24978302
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
26031990
Quarters > 0 > balance Sheet > property Plant Equipment
321400
Quarters > 0 > balance Sheet > total Assets
26820098
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1899094
Quarters > 0 > balance Sheet > equity
24921004
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-5087557
Quarters > 0 > cash Flow > depreciation
57344
Quarters > 0 > cash Flow > change In Working Capital
1449139
Quarters > 0 > cash Flow > cash From Operations
-3023874
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
10457629
Quarters > 0 > cash Flow > net Change In Cash
7433755
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6749679833270514
Quarters > 0 > ratios > PB
0.08801436687703271
Quarters > 0 > ratios > ROE
-20.414735297181448
Quarters > 0 > ratios > ROA
-18.969196160282486
Quarters > 0 > ratios > FCF
-3023874
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3663085
Quarters > 1 > income Statement > operating Income
-3663085
Quarters > 1 > income Statement > interest Expense
4998
Quarters > 1 > income Statement > pretax Income
-3489141
Quarters > 1 > income Statement > net Income
-3489141
Quarters > 1 > income Statement > eps
-1.8227443601166844
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1914224
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
17544547
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
20698494
Quarters > 1 > balance Sheet > property Plant Equipment
339653
Quarters > 1 > balance Sheet > total Assets
21562199
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2550214
Quarters > 1 > balance Sheet > equity
19011985
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3489140
Quarters > 1 > cash Flow > depreciation
57344
Quarters > 1 > cash Flow > change In Working Capital
-2876476
Quarters > 1 > cash Flow > cash From Operations
-5607467
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-5607467
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.8227443601166844
Quarters > 1 > ratios > PB
0.02929937005525725
Quarters > 1 > ratios > ROE
-18.3523235474886
Quarters > 1 > ratios > ROA
-16.181749366101297
Quarters > 1 > ratios > FCF
-5607467
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2988204
Quarters > 2 > income Statement > operating Income
-2988204
Quarters > 2 > income Statement > interest Expense
4998
Quarters > 2 > income Statement > pretax Income
-2788418
Quarters > 2 > income Statement > net Income
-2788418
Quarters > 2 > income Statement > eps
-1.505839112141735
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1851737
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
7290
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
23152014
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
23721541
Quarters > 2 > balance Sheet > property Plant Equipment
357278
Quarters > 2 > balance Sheet > total Assets
24660215
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2842270
Quarters > 2 > balance Sheet > equity
21817945
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2788420
Quarters > 2 > cash Flow > depreciation
57345
Quarters > 2 > cash Flow > change In Working Capital
784051
Quarters > 2 > cash Flow > cash From Operations
-1253503
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-1253503
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.505839112141735
Quarters > 2 > ratios > PB
0.024697810311649422
Quarters > 2 > ratios > ROE
-12.78038788712686
Quarters > 2 > ratios > ROA
-11.3073547817811
Quarters > 2 > ratios > FCF
-1253503
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
7292829
Quarters > 3 > income Statement > operating Income
-7292829
Quarters > 3 > income Statement > interest Expense
66700
Quarters > 3 > income Statement > pretax Income
-7112529
Quarters > 3 > income Statement > net Income
-7112529
Quarters > 3 > income Statement > eps
-3.8546156022280536
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1845198
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-6036
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
24405517
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
24681352
Quarters > 3 > balance Sheet > property Plant Equipment
374303
Quarters > 3 > balance Sheet > total Assets
25694396
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1771817
Quarters > 3 > balance Sheet > equity
23922579
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-7156950
Quarters > 3 > cash Flow > depreciation
57344
Quarters > 3 > cash Flow > change In Working Capital
-2232994
Quarters > 3 > cash Flow > cash From Operations
-8584779
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
12966891
Quarters > 3 > cash Flow > net Change In Cash
4382112
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-3.8546156022280536
Quarters > 3 > ratios > PB
0.022445431907655106
Quarters > 3 > ratios > ROE
-29.73144743298789
Quarters > 3 > ratios > ROA
-27.68124613631704
Quarters > 3 > ratios > FCF
-8584779
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
18066200
Annuals > 0 > income Statement > operating Income
-18066200
Annuals > 0 > income Statement > interest Expense
332720
Annuals > 0 > income Statement > pretax Income
-17542120
Annuals > 0 > income Statement > net Income
-17542120
Annuals > 0 > income Statement > eps
-9.164089469153035
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1914224
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3771
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
17544547
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
20698494
Annuals > 0 > balance Sheet > property Plant Equipment
339653
Annuals > 0 > balance Sheet > total Assets
21562199
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2550214
Annuals > 0 > balance Sheet > equity
19011985
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-17542120
Annuals > 0 > cash Flow > depreciation
229377
Annuals > 0 > cash Flow > change In Working Capital
-4396490
Annuals > 0 > cash Flow > cash From Operations
-19025205
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
12725954
Annuals > 0 > cash Flow > net Change In Cash
-6299251
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-9.164089469153035
Annuals > 0 > ratios > PB
0.02929937005525725
Annuals > 0 > ratios > ROE
-92.26874521518926
Annuals > 0 > ratios > ROA
-81.35589510142263
Annuals > 0 > ratios > FCF
-19025205
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
32179585
Annuals > 1 > income Statement > operating Income
-32179585
Annuals > 1 > income Statement > interest Expense
2893922
Annuals > 1 > income Statement > pretax Income
-32120533
Annuals > 1 > income Statement > net Income
-32120533
Annuals > 1 > income Statement > eps
-51.89041965599743
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
619007
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1816271
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
23843798
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
24048190
Annuals > 1 > balance Sheet > property Plant Equipment
406726
Annuals > 1 > balance Sheet > total Assets
25208345
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
9702130
Annuals > 1 > balance Sheet > equity
15506215
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-33006960
Annuals > 1 > cash Flow > depreciation
229377
Annuals > 1 > cash Flow > change In Working Capital
-86843
Annuals > 1 > cash Flow > cash From Operations
-27945024
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
17802939
Annuals > 1 > cash Flow > net Change In Cash
4382915
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-51.89041965599743
Annuals > 1 > ratios > PB
0.011616699304117734
Annuals > 1 > ratios > ROE
-207.14618622275003
Annuals > 1 > ratios > ROA
-127.42023722699764
Annuals > 1 > ratios > FCF
-27945024
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
45080448
Annuals > 2 > income Statement > operating Income
-45080448
Annuals > 2 > income Statement > interest Expense
4300150
Annuals > 2 > income Statement > pretax Income
-50255815
Annuals > 2 > income Statement > net Income
-50255815
Annuals > 2 > income Statement > eps
-137.95589490761455
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
364289
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1437481
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
19460883
Annuals > 2 > balance Sheet > short Term Investments
14477726
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
34041135
Annuals > 2 > balance Sheet > property Plant Equipment
80789
Annuals > 2 > balance Sheet > total Assets
35104730
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
5227270
Annuals > 2 > balance Sheet > total Liabilities
19764444
Annuals > 2 > balance Sheet > equity
15340286
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-50255820
Annuals > 2 > cash Flow > depreciation
229377
Annuals > 2 > cash Flow > change In Working Capital
-270439
Annuals > 2 > cash Flow > cash From Operations
-40252881
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
55373183
Annuals > 2 > cash Flow > net Change In Cash
819167
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-137.95589490761455
Annuals > 2 > ratios > PB
0.006910438240851572
Annuals > 2 > ratios > ROE
-327.60676691425437
Annuals > 2 > ratios > ROA
-143.1596682270452
Annuals > 2 > ratios > FCF
-40252881
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
27252977
Annuals > 3 > income Statement > operating Income
-27252977
Annuals > 3 > income Statement > interest Expense
2162989
Annuals > 3 > income Statement > pretax Income
-26084468
Annuals > 3 > income Statement > net Income
-26084468
Annuals > 3 > income Statement > eps
-104.40469100224144
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
249840
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
3287418
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
18641716
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
18779595
Annuals > 3 > balance Sheet > property Plant Equipment
118254
Annuals > 3 > balance Sheet > total Assets
20114594
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
12138686
Annuals > 3 > balance Sheet > total Liabilities
16443659
Annuals > 3 > balance Sheet > equity
3670935
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-26084470
Annuals > 3 > cash Flow > depreciation
229377
Annuals > 3 > cash Flow > change In Working Capital
2750786
Annuals > 3 > cash Flow > cash From Operations
-18990850
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
33120924
Annuals > 3 > cash Flow > net Change In Cash
14130074
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-104.40469100224144
Annuals > 3 > ratios > PB
0.019805155907146273
Annuals > 3 > ratios > ROE
-710.5674167480493
Annuals > 3 > ratios > ROA
-129.67931642070428
Annuals > 3 > ratios > FCF
-18990850
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
15
Valuation > metrics > PE
-0.6749679833270514
Valuation > metrics > PB
0.08801436687703271
Valuation > final Score
70
Valuation > verdict
91.2% Undervalued
Profitability > metrics > ROE
-20.414735297181448
Profitability > metrics > ROA
-19.543480924815967
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.07620455419853871
Risk > metrics > Interest Coverage
-2656.9105077928607
Risk > final Score
-10568
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-2872
Prev Risks > 1
-2332
Prev Risks > 2
-377
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T21:29:38.283Z
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABioVie Inc. Announces Pricing of $12 Million Public Offering GlobeNewswire
Read more →Showing 2 of 3
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BioVie Inc. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.